K. Otsuka

发表

Rebiopsy of non-small cell lung cancer patients with acquired resistance to EGFR-TKI: Comparison between T790M mutation-positive and -negative populations.

K. Kunimasa, T. Ishida, S. Nanjo, 2012 .

Clinical Features and Outcome of Acute Exacerbation of Interstitial Pneumonia: Collagen Vascular Diseases-Related versus Idiopathic

S. Nanjo, N. Katakami, R. Tachikawa, 2011, Respiration.

A new strategy for metachronous primary lung cancer: stereotactic body radiation therapy with concurrent chemotherapy.

K. Takayama, M. Kokubo, S. Fujita, 2015, Anticancer research.

Amrubicin at a lower-dose with routine prophylactic use of granulocyte-colony stimulating factor for relapsed small-cell lung cancer.

T. Nishimura, S. Nanjo, S. Fujita, 2011, Lung cancer.

Detection of Herpes Viruses by Multiplex and Real-Time Polymerase Chain Reaction in Bronchoalveolar Lavage Fluid of Patients with Acute Lung Injury or Acute Respiratory Distress Syndrome

R. Seo, R. Tachikawa, H. Hashimoto, 2013, Respiration.

Rebiopsy of non–small cell lung cancer patients with acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor

K. Kunimasa, T. Ishida, S. Nanjo, 2013, Cancer.

Role of sedation for agitated patients undergoing noninvasive ventilation: clinical practice in a tertiary referral hospital

M. Mishima, K. Chin, R. Tachikawa, 2015, BMC Pulmonary Medicine.

Preexisting interstitial lung disease is inversely correlated to tumor epidermal growth factor receptor mutation in patients with lung adenocarcinoma.

N. Katakami, A. Hata, R. Tachikawa, 2013, Lung cancer.

Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations

S. Fujita, N. Katakami, A. Hata, 2015, BMC Cancer.

EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer

S. Fujita, N. Katakami, A. Hata, 2015, Cancer Chemotherapy and Pharmacology.

Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: clinical benefit with optimal patient selection.

S. Morita, K. Kunimasa, T. Ishida, 2011, Lung cancer.

Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis

N. Katakami, D. Fujimoto, K. Otsuka, 2014, Clinical & Experimental Metastasis.

Cytokeratin 19 Fragment Predicts the Efficacy of Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor in Non–Small-Cell Lung Cancer Harboring EGFR Mutation

S. Fujita, N. Katakami, A. Hata, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial lung disease

N. Katakami, D. Fujimoto, K. Otsuka, 2014, Cancer Chemotherapy and Pharmacology.

Malignant melanoma of the lung: report of two cases.

N. Katakami, T. Komatsu, S. Neri, 2011, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health‐related quality of life in patients with interstitial lung disease

R. Tachikawa, K. Otsuka, K. Tomii, 2012, Respirology.

Weekly administration of paclitaxel and carboplatin with concurrent thoracic radiation in previously untreated elderly patients with locally advanced non-small-cell lung cancer: A case series of 20 patients.

K. Takayama, M. Kokubo, S. Fujita, 2014, Molecular and clinical oncology.

Bevacizumab plus weekly paclitaxel with or without carboplatin for previously-treated non-squamous non-small cell lung cancer.

S. Fujita, N. Katakami, A. Hata, 2014, Anticancer research.

Early pulmonary involvement of anti-CADM-140 autoantibody-positive rapidly progressive interstitial lung disease preceding typical cutaneous symptoms.

R. Tachikawa, Y. Hosono, H. Ueda, 2014, Internal medicine.

Prognostic impact of central nervous system metastases after acquired resistance to EGFR-TKI: poorer prognosis associated with T790M-negative status and leptomeningeal metastases.

K. Kunimasa, T. Ishida, Y. Nishimura, 2015, Anticancer research.

Crizotinib administered via nasogastric and percutaneous endoscopic gastrostomy tubes for the successful treatment of ALK-rearranged lung cancer in a patient with poor performance status.

N. Katakami, R. Tachikawa, K. Otsuka, 2013, Respiratory investigation.

Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis

N. Katakami, D. Fujimoto, K. Otsuka, 2014, Clinical & Experimental Metastasis.

Evaluation of discomfort and tolerability to bronchoscopy according to different sedation procedures with midazolam.

D. Fujimoto, K. Otsuka, K. Tomii, 2015, Experimental and therapeutic medicine.

Prognostic value of bronchoalveolar lavage in patients with non-HIV pneumocystis pneumonia.

R. Tachikawa, D. Fujimoto, Kosuke Tanaka, 2014, Internal medicine.

Serum procalcitonin is a valuable diagnostic marker in acute exacerbation of interstitial pneumonia

R. Tachikawa, Kosuke Tanaka, K. Otsuka, 2013, Respirology.

Validation of an Ion Torrent Sequencing Platform for the Detection of Gene Mutations in Biopsy Specimens from Patients with Non-Small-Cell Lung Cancer

S. Fujita, N. Katakami, A. Hata, 2015, PloS one.